logo
Plus   Neg
Share
Email

Deutsche Bank Reaffirms Financial Targets

German banking major Deutsche Bank AG (DB) on Tuesday reported progress on its transformation strategy, in line with or ahead of its objectives. The bank further reaffirmed its 2019, 2020 and 2022 cost targets.

The company expects adjusted costs, before transformation-related charges and the impact of the Global Prime Finance transfer to BNP Paribas, to be 21.5 billion euros in the full year 2019. The company has a cost target of 19.5 billion euros in 2020 and of 17 billion euros in 2022, a reduction of nearly 6 billion euros relative to 2018.

Further, Deutsche Bank maintained a Common Equity Tier 1 or CET 1 ratio of at least 12.5% at all times throughout its transformation. Asset reduction in the Capital Release Unit is running ahead of plan. For the end of 2019, the bank currently anticipates it will report a CET 1 ratio of above 13%.

The company also reaffirmed its target of an 8% post-tax return on tangible equity or RoTE in 2022.

For the Core Bank, which excludes the Capital Release Unit, Deutsche Bank announced a post-tax RoTE target of above 9% in 2022.

Christian Sewing, Chief Executive Officer, said, "In the past few months we have made significant progress on every dimension of our strategic transformation. We are in line with our plan and even ahead in several areas."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Facebook has unveiled Instagram Reels as its answer to the popular Chinese-owned video app TikTok. The social media giant said in a blog post that Instagram Reels is a new way to create short, entertaining videos on Facebook's photo-sharing app Instagram. Facebook reportedly shut down its TikTok clone Lasso in July, ahead of the launch of Instagram Reels. WD-40 Company recalled about 130,000 units of X-14 Mildew Stain Remover for potential risk of skin irritation, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said pressure can build up inside the bottle and cause it to fall over and leak, posing a risk of skin irritation. Biopharmaceutical company Bristol-Myers Squibb Co. on Thursday reported a loss for the second quarter, compared to a profit last year, hurt primarily by hefty amortization expenses. However, adjusted earnings per share and quarterly revenues topped analysts' expectations. Looking ahead, the company raised its adjusted earnings and revenue outlook for the full-year 2020.
Follow RTT